Sweta Kothari: Clinical Assessment of Thrombocytopenia Beyond Platelet Count
Sweta Kothari, Assistant Professor at Bharti Vidyapeeth, shared a post on LinkedIn:
“Platelet count is just one part of the picture—the number alone doesn’t tell the whole story.
When assessing bleeding risk and platelet health, we evaluate the complete clinical context:
Symptoms: Unexplained bruising, gum bleeding, nosebleeds, or red pinprick spots (petechiae).
The Trend: Whether the count is stable, steadily declining, or dropping rapidly.
Underlying Conditions: Bone marrow disorders, infections, autoimmune conditions, or other illnesses.
Medications: Certain prescription drugs and supplements that may lower platelets.
There is no single ‘safe’ or ‘dangerous’ cutoff—treatment decisions always depend on your overall health, history, and symptoms.
Consult a hematologist for a thorough clinical evaluation.”
Stay updated with Hemostasis Today.
-
Oct 13, 2026, 02:01Nour Al-Mozain: Is It Really Anti-D? – Unraveling Auto-Anti-LW in the Transfusion Laboratory
-
Oct 13, 2026, 01:51Berenice Villegas: The Role of Morphologic Evaluation in Body Fluid Differential Analysis
-
Oct 13, 2026, 01:44Debadrita Ray: Evaluating vWF and VITRO Score for Detecting CSPH in cACLD Patients
-
Oct 13, 2026, 01:34Nagesh Ramesh: Donating Blood for International Plasma Awareness Week
-
Oct 12, 2026, 21:51Sam Botchey: Orthobiologics Are Advancing but the Evidence Must Keep Pace
-
Oct 12, 2026, 21:50Serum Vitamin D, Platelet Function, and Bleeding in Primary ITP – Platelets Journal
-
Oct 12, 2026, 21:30Nika Samadzadeh Tabrizi: Looking Forward to the PACeS Trial on Anticoagulation for POAF
-
Oct 12, 2026, 21:28Michael Megaly: Does Coronary Ectasia Affect Outcomes in Acute Coronary Syndromes?
-
Oct 12, 2026, 21:25Vitor Borin P. de Souza: Think Twice Before Anticoagulating an Isolated Subsegmental PE